azoxymethane has been researched along with aspirin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 5 (22.73) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn, DM; Landers, M; Pence, BC; Wargovich, MJ; Zhao, C | 1 |
| Chen, CD; Harris, C; Velasco, M; Wargovich, MJ; Yang, E | 1 |
| Kelloff, G; Rao, CV; Reddy, BS; Rivenson, A | 1 |
| Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL | 1 |
| Bernheim, J; Bomstein, Y; Buklan, G; Kariv, N; Shalev, M; Shpitz, B | 1 |
| Conran, P; Hawk, EE; Kelloff, GJ; Kramer, PM; Li, H; Lubet, RA; Pereira, MA; Schut, HA; Steele, VE | 1 |
| Meyer, O; Mølck, AM; Poulsen, M | 1 |
| Abarrategui, C; Carrasco, C; Escribano, M; García-Mendez, A; López-Farré, A; Manzarbeitia, F; Martín, MJ; Molero, L; Porres Cubero, JC; Rico, L; Sánchez-Fayos, P; Vázquez, M | 1 |
| Hellerstein, MK; Killion, S; Kim, SJ; Turner, S | 1 |
| Khor, TO; Kong, AN; Kopelovich, L; Rao, CV; Reddy, BS; Steele, VE; Wang, CX; Zheng, X | 1 |
| Kopelovich, L; Liu, X; Ouyang, N; Patlolla, JM; Rao, CV; Reddy, BS; Rigas, B; Simi, B; Steele, VE; Wang, CX | 1 |
| Hao, X; Huang, MT; Ju, J; Liu, Y; Newmark, H; Reddy, BS; Simi, B; Xiao, H; Yang, CS | 1 |
| Bouhadjar, M; Bousserouel, S; Gosse, F; Marescaux, J; Raul, F; Soler, L | 1 |
| Chaudhary, A; Huang, Y; Prabhu, S; Sutaria, D; Wang, J | 1 |
| Barnholtz-Sloan, JS; Chen, Y; Dawson, DM; Fink, SP; Kopelovich, L; Kresak, A; Lawrence, EG; Markowitz, SD; Willis, JE; Yang, P; Zhang, Y | 1 |
| Guo, Y; Huang, MT; Kong, AN; Li, W; Liu, Y; Su, ZY; Zhang, C | 1 |
| Biddick, L; Janakiram, NB; Li, Q; Lightfoot, S; Lubet, RA; Madka, V; Miller, MS; Mohammed, A; Rao, CV; Sei, S; Singh, A; Steele, VE; Suen, CS; Zhang, Y | 1 |
| Hartung, NM; Kühl, AA; McDonald, FM; Ostermann, AI; Rohwer, N; Schebb, NH; Weylandt, KH; Zopf, D | 1 |
| Bian, X; Chan, AWH; Chan, FKL; Coker, OO; El-Omar, E; Nakatsu, G; Sung, JJY; Wei, H; Wu, J; Yu, J; Zhao, L; Zhao, R; Zhou, Y | 1 |
| Chen, L; Cheung, S; Feng, Y; He, W; Li, Z; McDonald, F; Tao, L; Wang, G; Yang, J; Yang, M; Zhang, Y; Zhong, X | 1 |
| Chen, Y; Diao, T; Li, D; Shang, G; Shi, L; Sun, L; Yin, X | 1 |
| Jiang, Q; Jones-Hall, Y; Liu, KY; Nakatsu, CH; Wang, Q | 1 |
22 other study(ies) available for azoxymethane and aspirin
| Article | Year |
|---|---|
Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Azoxymethane; Biomarkers, Tumor; Body Weight; Calcium; Cholic Acid; Cholic Acids; Colon; Colonic Neoplasms; Eating; Intestinal Mucosa; Male; Ornithine Decarboxylase; Protein Kinase C; Rats; Rats, Inbred F344 | 1995 |
Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
Topics: Acetaminophen; Adenoma; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Fenretinide; Ibuprofen; Isotretinoin; Male; Piroxicam; Precancerous Conditions; Rats; Rats, Inbred F344 | 1995 |
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Aspirin; Azoxymethane; Body Weight; Colonic Neoplasms; Dinoprostone; Male; Rats; Rats, Inbred F344 | 1993 |
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1998 |
Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azoxymethane; Carcinogens; Chemoprevention; Colon; Colonic Neoplasms; Male; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |
Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
Topics: Animals; Aspirin; Azoxymethane; Colon; Colonic Neoplasms; Dinoprostone; Dose-Response Relationship, Drug; Eflornithine; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 1999 |
The combination of 1alpha,25(OH2)-vitamin D3, calcium and acetylsalicylic acid affects azoxymethane-induced aberrant crypt foci and colorectal tumours in rats.
Topics: Animals; Aspirin; Azoxymethane; Body Weight; Calcitriol; Calcium; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eating; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344 | 2002 |
Aspirin inhibits endothelial nitric oxide synthase (eNOS) and Flk-1 (vascular endothelial growth factor receptor-2) prior to rat colon tumour development.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Azoxymethane; Caspase 3; Caspases; Colon; Colonic Neoplasms; Immunoenzyme Techniques; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred WKY; Regional Blood Flow; Up-Regulation; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
In vivo measurement of DNA synthesis rates of colon epithelial cells in carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Azoxymethane; Body Water; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cholic Acid; Colon; Colonic Neoplasms; Deuterium; DNA; Epithelial Cells; Gas Chromatography-Mass Spectrometry; Kinetics; Male; Rats; Rats, Sprague-Dawley | 2005 |
Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aspirin; Atorvastatin; Azoxymethane; Carcinogens; Celecoxib; Cell Growth Processes; Colonic Neoplasms; Dose-Response Relationship, Drug; Heptanoic Acids; Male; Pyrazoles; Pyrroles; Rats; Rats, Inbred F344; Sulfonamides | 2006 |
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Topics: Acetates; Animals; Antineoplastic Agents; Aspirin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Humans; Indoles; Male; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344 | 2006 |
Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azoxymethane; Calcium, Dietary; Carcinogens; Colon; Colonic Neoplasms; Dietary Fats; Disease Models, Animal; Drug Therapy, Combination; Female; Male; Mice; Rats | 2008 |
Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Azoxymethane; Carcinogens; Carcinoma; Cell Transformation, Neoplastic; Colonic Neoplasms; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Immunity, Innate; Inflammation Mediators; Male; Neoplasms, Experimental; Rats; Rats, Wistar; Time Factors | 2010 |
Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Azoxymethane; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Drug Delivery Systems; Folic Acid; Lactic Acid; Male; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vitamin B Complex | 2011 |
Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Azoxymethane; Carcinogens; Celecoxib; Chemoprevention; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Hydroxyprostaglandin Dehydrogenases; Inflammation; Intestinal Mucosa; Membrane Proteins; Mice; Mice, Knockout; Pyrazoles; Sulfonamides; Sulindac | 2015 |
The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Dextran Sulfate; Epigenesis, Genetic; Histone Deacetylases; Histones; Lysine; Male; Mice, Inbred Strains; Neoplasms, Experimental; Nitric Oxide Synthase Type II | 2016 |
Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
Topics: Adenocarcinoma; Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azoxymethane; Carcinogens; Colonic Neoplasms; Dose-Response Relationship, Drug; Male; Naproxen; Neoplasm Invasiveness; Rats; Rats, Wistar | 2019 |
Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Azoxymethane; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Colitis-Associated Neoplasms; Colorectal Neoplasms; Dextran Sulfate; Dose-Response Relationship, Drug; Female; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 2020 |
Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Bacterial Agents; Anticarcinogenic Agents; Aspirin; Azoxymethane; Bacillaceae; Bacteroides fragilis; Bacteroidetes; Biological Availability; Carcinogenesis; Colitis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; DNA, Bacterial; Dose-Response Relationship, Drug; Feces; Gastrointestinal Microbiome; Germ-Free Life; Humans; Intestinal Mucosa; Male; Mice; Mice, Transgenic; RNA, Ribosomal, 16S | 2020 |
Aspirin inhibits prostaglandins to prevents colon tumor formation via down-regulating Wnt production.
Topics: Animals; Aspirin; Azoxymethane; Cell Transformation, Neoplastic; Colitis; Colitis-Associated Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Down-Regulation; Humans; Male; Mice; Nuclear Receptor Subfamily 4, Group A, Member 2; Proteomics; Proto-Oncogene Proteins; Wnt Proteins; Wnt Signaling Pathway | 2021 |
Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation.
Topics: Animals; Apoptosis; Aspirin; Azoxymethane; Carcinogenesis; Cell Proliferation; Colitis, Ulcerative; Colorectal Neoplasms; Cyclin D1; Dextran Sulfate; Hyperplasia; Inflammation; Interleukin-10; Interleukin-6; Janus Kinases; Mice; Proliferating Cell Nuclear Antigen; Signal Transduction; STAT3 Transcription Factor | 2022 |
Combining gamma-tocopherol and aspirin synergistically suppresses colitis-associated colon tumorigenesis and modulates the gut microbiota in mice, and inhibits the growth of human colon cancer cells.
Topics: Animals; Aspirin; Azoxymethane; Carcinogenesis; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Dextran Sulfate; gamma-Tocopherol; Gastrointestinal Microbiome; Humans; Mice; Mice, Inbred C57BL | 2023 |